Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Reagan-Udall Foundation's Board of Directors

This article was originally published in The Tan Sheet

Executive Summary

Former FDA Commissioner Mark McClellan is chairman of the Reagan-Udall Foundation's board of directors, which also includes four ex officio members from HHS. The 2007 law which created the foundation specified that the board include four representatives of industry, three from academic research organizations, two from patient advocacy groups, one health care provider and four at-large members with relevant "expertise or experience." The outside members are listed below.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS101624

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel